多发性硬化、抑郁、血管疾病与死亡率的交互作用:基于人群的匹配队列研究
该研究基于英格兰人群匹配队列,纳入12,251例多发性硬化(MS)患者和72,572例对照,评估抑郁与血管疾病及死亡率的关联。结果显示,MS患者无论是否合并抑郁,血管疾病风险均增加;抑郁与MS对全因死亡率存在协同交互作用,14%的效应归因于交互作用。
要点
- MS患者血管疾病风险增加,与是否合并抑郁无关。
- MS合并抑郁者10年全因死亡风险为对照无抑郁者的5.43倍。
- 抑郁与MS对全因死亡率存在协同交互作用,14%效应归因于交互。
核心结论
- 抑郁与MS对全因死亡率的影响呈协同作用,14%的观察效应归因于交互作用。
- MS患者无论是否合并抑郁,血管疾病风险均增加。
研究设计与样本
- 基于人群的回顾性匹配队列研究,1987年1月1日至2018年9月30日,英格兰。
- 纳入12,251例MS患者和72,572例按年龄、性别和全科诊所匹配的无MS对照。
- 采用时变Cox比例风险回归模型分析MS、抑郁与血管疾病及死亡率的关联,并按性别分层。
主要发现
- 基线时,21%的MS患者和9%的对照存在抑郁。
- 与无抑郁的匹配对照相比,MS患者无论是否合并抑郁,新发血管疾病风险均增加。
- 10年全因死亡风险:伴抑郁的对照为1.75倍(95%CI 1.59-1.91),无抑郁的MS患者为3.88倍(95%CI 3.66-4.10),合并抑郁的MS患者为5.43倍(95%CI 4.88-5.96)。
- 性别分层分析证实风险比存在差异。
临床怎么用
- 在MS管理中应关注抑郁的筛查与治疗,因其与血管疾病和死亡风险增加相关。
- 对MS患者进行血管疾病风险评估时,无论有无抑郁均应警惕。
局限性
- 进一步研究需评估有效治疗抑郁是否与降低血管疾病和死亡风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To assess whether the association among depression, vascular disease, and mortality differs in people with multiple sclerosis (MS) compared with age-, sex-, and general practice-matched controls. METHODS: We conducted a population-based retrospective matched cohort study between January 1, 1987, and September 30, 2018, that included people with MS and matched controls without MS from England, stratified by depression status. We used time-varying Cox proportional hazard regression models to test the association among MS, depression, and time to incident vascular disease and mortality. Analyses were also stratified by sex. RESULTS: We identified 12,251 people with MS and 72,572 matched controls. At baseline, 21% of people with MS and 9% of controls had depression. Compared with matched controls without depression, people with MS had an increased risk of incident vascular disease regardless of whether they had comorbid depression. The 10-year hazard of all-cause mortality was 1.75-fold greater in controls with depression (95% confidence interval [CI] 1.59-1.91), 3.88-fold greater in people with MS without depression (95% CI 3.66-4.10), and 5.43-fold greater in people with MS and depression (95% CI 4.88-5.96). Overall, the interaction between MS status and depression was synergistic, with 14% of the observed effect attributable to the interaction. Sex-stratified analyses confirmed differences in hazard ratios. DISCUSSION: Depression is associated with increased risks of incident vascular disease and mortality in people with MS, and the effects of depression and MS on all-cause mortality are synergistic. Further studies should evaluate whether effectively treating depression is associated with a reduced risk of vascular disease and mortality.
引用
- Palladino R, Chataway J, Majeed A, et al. Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study. Neurology. 2021. PMID: 34470802. doi:10.1212/WNL.0000000000012610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。